To determine the primary site of abnormal constitutive production of IFN-α in individuals with AGS, we first quantified IFN-α concentrations using Simoa from paired blood-CSF samples in control individuals (Figure 1A). The gene discussed is IFNA17; the disease is Aicardi-Goutieres syndrome.